Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state
- PMID: 6179603
Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state
Abstract
We have attempted to identify the antigen on L5178Y cells that is the target for peritoneal cytotoxic T-lymphocytes (CTL) generated in L5178Y-O (original) immunized and challenged DBA/2 mice during establishment of the L5178Y cell tumor dormant state. These CTL exhibited in vitro lytic activity against methylcholanthrene-induced L5178Y and P815Y cells as well as Gross virus-induced BALB/c cells but not against a variety of other H-2d-tumor cell lines. The pattern of susceptibility to cell-mediated immune cytolysis was identical to the pattern of AB-dependent complement-mediated cytolysis produced by a rabbit anti-L5178Y antiserum. Quantitative expression of surface H-2d determinants was not a limiting factor in tumor cell lysis by CTL. The degree of CTL lysis of the susceptible cell lines was directly related to the amount of tumor-associated antigen expressed on the cell surface. The pattern of in vitro susceptibility to CTL lysis correlated well with in vivo transplantation resistance. The L5178Y cell antigen target for both CTL and Ra-anti-L5178Y serum lysis is likely to be either an endogenous AKR ecotropic viral glycoprotein with a molecular weight of 71,000 or one of two cell surface determinants, at Mr 85,000 and 135,000. These higher-molecular-weight antigens are neither endogenous AKR ecotropic viral-induced nor murine leukemia virus group-specific precursor structural proteins but may be transformation antigens shared by the susceptible tumor cell lines.
Similar articles
-
The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.J Immunol. 1986 Mar 15;136(6):2271-9. J Immunol. 1986. PMID: 3005407
-
Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.J Immunol. 1983 Dec;131(6):3078-84. J Immunol. 1983. PMID: 6605998
-
Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.J Immunol. 1987 Oct 1;139(7):2464-73. J Immunol. 1987. PMID: 2821116
-
Surface markers, antigens, and receptors on murine T and B cells: part 2.Crit Rev Immunol. 1983;4(1):19-94. Crit Rev Immunol. 1983. PMID: 6131792 Review.
-
Development of tumors as a result of graft-versus-host reaction.Exp Hematol. 1973;1(3):135-49. Exp Hematol. 1973. PMID: 4153858 Review. No abstract available.
Cited by
-
Pattern of organ colonization of metastasizing mouse L929-MM4 cells and the stimulation of lung tumor formation by cyclophosphamide.Clin Exp Metastasis. 1984 Jul-Sep;2(3):241-50. doi: 10.1007/BF00132931. Clin Exp Metastasis. 1984. PMID: 6543702
-
Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state.Cancer Immunol Immunother. 1983;16(1):59-64. doi: 10.1007/BF00199907. Cancer Immunol Immunother. 1983. PMID: 6139161 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical